The recommendation by the CHMP should now result in approval of Arexvy in the broader age range in February next year, and ...
GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory syncytial virus (RSV) ...
CAMBRIDGE, MA / ACCESS Newswire / June 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA® (mRNA-1345), the Company’s ...
Clinical Trials Arena on MSN
Blue Lake restarts paediatric RSV vaccine study after FDA clinical hold
After a Type C discussion, Blue Lake got the FDA nod to enrol both RSV-positive and negative children above the age of 18 months in the study. This leaves the US-based biotech open to potentially ...
There is underreporting of adverse effects from vaccines; but, in the vast majority of cases, the side effects from the ...
In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. Moderna, Inc. is placed among them. Moderna, Inc. (NASDAQ:MRNA), a Cambridge-based biotechnology leader, ...
Research led by the Veterans Affairs Portland Health Care System in Portland, Oregon, found that a single dose of respiratory ...
It may feel like you are surrounded by sniffles and coughs, but flu season activity is still low in many parts of the U.S.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback